Kanna Benefits: What Research Says About Mood & Anxiety

Interest in kanna (Sceletium tortuosum) has grown steadily as consumers search for natural ways to support mood and manage everyday stress. But unlike many botanical wellness trends, kanna comes with a growing body of scientific research — not just centuries of traditional use. 

This article breaks down what the evidence actually shows about kanna's effects on mood and anxiety, where the science is promising, and where it still has room to grow. Brands like Kamello are bringing kanna into accessible daily formats, making it worth understanding what you're actually consuming.

How Kanna Affects the Brain: Mechanisms of Action

Before looking at clinical outcomes, it helps to understand why kanna might influence mood and anxiety at a biochemical level. 

A peer-reviewed review of kanna's phytochemistry and clinical potential identifies mesembrine-type alkaloids as the plant's primary active compounds, with two key mechanisms driving their effects. 

A separate scientific review published in PMC links these same alkaloids to both antidepressant and anxiolytic activity across preclinical and clinical contexts — providing the biological rationale for studying kanna in mood and stress regulation.

Serotonin Reuptake Inhibition

Mesembrine, the most abundant alkaloid in kanna, inhibits the reuptake of serotonin in the brain — slowing its removal from synaptic gaps and allowing it to remain active longer. This is the same general mechanism used by a class of prescription antidepressants, though kanna operates at much lower potency and through a naturally derived compound rather than a synthetic one.

PDE4 Inhibition

Mesembrenone contributes a second distinct mechanism: phosphodiesterase-4 (PDE4) inhibition. PDE4 enzymes are involved in neuroinflammatory signaling and stress pathway regulation. Inhibiting them has been linked to reduced anxiety-like behavior in preclinical models.

A pharmacological study using an animal anxiety-depression model observed mood and anxiety-related effects from kanna extracts, supporting the idea that these alkaloids influence overlapping stress, anxiety, and depression pathways — though animal research doesn't directly translate to human outcomes.

Neuroimaging Evidence: What Happens in the Brain

One of the most compelling pieces of human evidence comes from brain imaging research. A pharmaco-fMRI study published in Neuropsychopharmacology tested a standardized kanna extract (Zembrin®) in healthy adults and found measurable changes in brain activity after a single 25 mg dose.

Specifically, researchers observed reduced activation in the amygdala — the region most associated with threat detection, fear, and anxiety — along with weakened connectivity between the amygdala and related stress-response circuits. This moves beyond self-reported mood data to objective neurobiological measurement.

Clinical Trial Evidence: Mood, Anxiety & Stress

Improvements in Anxiety and Stress Scores

A peer-reviewed overview of clinical trials on kanna published in PMC summarizes findings from small trials using Zembrin®. In one six-week study, participants reported improved anxiety scores compared to baseline. Shorter trials also showed reductions in perceived stress. These outcomes — while preliminary — are consistent with the mechanistic evidence and with what traditional users have described for generations.

Early Evidence on Mood and Performance

Beyond anxiety, a PubMed-indexed clinical study on ergogenic effects of Zembrin® tracked mood questionnaires and performance measures after eight days of supplementation. The findings suggested positive mood-related outcomes alongside other measures, pointing toward kanna's potential across multiple psychological dimensions — not just anxiety relief in isolation.

What the Comprehensive Review Found

The most rigorous analysis of kanna's anxiety evidence to date is a systematic review and meta-analysis published on ResearchGate, which pooled data from randomized controlled trials comparing kanna extracts to placebo. Its conclusion is worth stating plainly: the review did not find statistically significant evidence that kanna extract reduces anxiety compared to placebo across the available trial data.

This doesn't mean kanna doesn't work — it means the current body of randomized trial evidence isn't yet large or consistent enough to confirm the effect at a clinical level. Small sample sizes, short durations, and variation in extract standardization all contribute to this gap.

Safety and Research Limitations

According to the Operation Supplement Safety (OPSS) program, existing studies on kanna have been small, short-term, and primarily conducted using a single proprietary extract. This makes it difficult to generalize findings to all kanna products on the market — particularly those using unstandardized raw material.

Key Safety Considerations

The most important safety note is kanna's serotonergic activity. Combining kanna with SSRIs, SNRIs, MAOIs, or other serotonin-affecting medications carries a theoretical risk of serotonin syndrome and warrants a conversation with a healthcare provider before use.

Pregnant or breastfeeding individuals and those with mood disorders should also exercise caution. At the doses found in functional beverages and standard supplements, kanna is generally well tolerated in healthy adults — but individual responses vary.

Where the Research Is Heading

Scientific interest in kanna is not slowing down. A registered clinical trial on ClinicalTrials.gov is currently investigating the effects of an eight-week course of kanna extract supplementation on mood, stress, and psychological measures in adults. This represents a meaningful step forward — longer duration, registered methodology, and a broader psychological scope than most prior studies.

As more trials are completed and published, the evidence base will strengthen. The early signals — neuroimaging data, mechanistic research, and small-scale clinical findings — point in a consistent direction. The science is still building, but it's building on a solid foundation.

Evidence Summary: What Research Supports

Kanna vs. Caffeine: A Different Kind of Mental Lift

Most people reach for caffeine when they need a mood boost — but caffeine works by blocking adenosine receptors and spiking cortisol, sharpening alertness while also raising anxiety and disrupting sleep. Kanna operates through an entirely different pathway, modulating serotonin availability and dampening stress signaling rather than stimulating the nervous system.

This makes it a compelling option for anyone who finds caffeine worsens anxiety or triggers a midday crash. Kanna's mood support doesn't come with a jittery edge — which is why it pairs naturally with kava in caffeine-free formulas that target emotional uplift and physical relaxation without relying on stimulants.

Try the Research-Backed Pairing

Understanding the science makes choosing a kanna product easier — especially when that product is also transparent about what's in it. Kamello combines 50 mg of kanna extract with 50 mg of kavalactones per can, pairing kanna's serotonergic mood support with kava's GABAergic relaxation for a layered, caffeine-free effect. 

Try Citrus Blossom, Spiced Coffee, or Peach and Black Tea — or explore the full Shop to find the right fit. For a detailed breakdown of how each ingredient contributes to the formula, visit the Product Benefits page.

Frequently Asked Questions

How much kanna extract has been used in clinical studies? 

Most clinical research has used a standardized extract called Zembrin®, typically at doses between 8 mg and 25 mg per day. These are relatively modest amounts — and notably lower than some supplement products on the market. The dose found effective in the fMRI study was a single 25 mg dose, suggesting effects are possible even at low concentrations in standardized form.

Does kanna work differently for anxiety vs. mood? 

The mechanisms overlap significantly. Serotonin reuptake inhibition influences both anxiety and mood, while PDE4 inhibition is more closely tied to stress pathway modulation. In practice, many users report both effects together — a calmer baseline emotional state paired with a gentle mood lift — rather than one distinct from the other.

How long does it take to notice kanna's effects on mood? 

Acute effects — particularly in beverage or sublingual form — can be felt within 20–45 minutes. Clinical trials assessing mood and anxiety outcomes typically ran between six and eight weeks, suggesting some benefits may build with consistent use over time rather than appearing immediately. The fMRI study did find measurable brain changes after a single dose.

Is there a risk of dependency with kanna? 

No strong evidence of physical dependency has been documented with kanna at typical doses. Some anecdotal reports suggest diminishing mood-lifting effects with very frequent daily use — a form of tolerance rather than dependence. Traditional use patterns involved periodic rather than daily consumption, which many modern users mirror as a precaution.

Why does the meta-analysis show mixed results if individual studies are positive? 

Meta-analyses combine multiple studies, which can dilute results when methods, extracts, dosages, and participants vary. The mixed findings reflect small sample sizes and inconsistent protocols — not necessarily a lack of effect. Larger, well-designed trials are still needed.

Can kanna help with stress that isn't classified as an anxiety disorder? 

This is where the most consistent evidence sits. Short clinical trials showed reductions in perceived stress in healthy adults — not those diagnosed with anxiety disorders. Kanna appears most well-supported as a tool for everyday stress management and mood support rather than as a clinical intervention for diagnosed conditions.

Does kanna interact with caffeine? 

There is no established interaction between kanna and caffeine, but the two have broadly opposing mechanisms — caffeine is stimulating while kanna is calming. Kamello's beverages are caffeine-free by design, allowing kanna's effects to come through without the edge or crash that caffeine can introduce.